Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Common Equity (2016 - 2025)

Historic Common Equity for CV Sciences (CVSI) over the last 14 years, with Q3 2025 value amounting to $1.5 million.

  • CV Sciences' Common Equity fell 2975.81% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 million, marking a year-over-year decrease of 2975.81%. This contributed to the annual value of $1.8 million for FY2024, which is 3816.74% down from last year.
  • CV Sciences' Common Equity amounted to $1.5 million in Q3 2025, which was down 2975.81% from $1.8 million recorded in Q2 2025.
  • Over the past 5 years, CV Sciences' Common Equity peaked at $12.0 million during Q1 2021, and registered a low of -$777000.0 during Q4 2022.
  • In the last 5 years, CV Sciences' Common Equity had a median value of $2.5 million in 2024 and averaged $3.8 million.
  • Per our database at Business Quant, CV Sciences' Common Equity plummeted by 12193.06% in 2022 and then soared by 47361.65% in 2023.
  • CV Sciences' Common Equity (Quarter) stood at $3.5 million in 2021, then tumbled by 121.93% to -$777000.0 in 2022, then soared by 473.62% to $2.9 million in 2023, then tumbled by 38.17% to $1.8 million in 2024, then fell by 14.26% to $1.5 million in 2025.
  • Its Common Equity was $1.5 million in Q3 2025, compared to $1.8 million in Q2 2025 and $1.9 million in Q1 2025.